UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 444

Sortiert nach

Neoadjuvant Androgen Deprivation Therapy for Prostate Volume Reduction, Lower Urinary Tract Symptom Relief and Quality of Life Improvement in Men with Intermediate- to High-risk Prostate Cancer: A Randomised Non-inferiority Trial of Degarelix versus Goserelin plus Bicalutamide

Clinical oncology (Royal College of Radiologists (Great Britain)), 2013-03, Vol.25 (3), p.190-196

2013

Volltextzugriff (PDF)

Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology group

Cancer radiothérapie, 2020-12, Vol.24 (8), p.892-897

2020

Volltextzugriff (PDF)

Concurrent Chemoradiation Therapy Versus Acceleration of Radiation Therapy With or Without Concurrent Chemotherapy in Locally Advanced Head and Neck Carcinoma (GORTEC 99-02): 7-Year Survival Data From a Phase 3 Randomized Trial and Prognostic Factors

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E324-E325

2016

Volltextzugriff (PDF)

Late toxicity and quality of life from GETUG-AFU 22 study: A randomized phase II trial comparing 6 months of degarelix in combination with radiotherapy to radiotherapy alone for patients with detectable PSA after radical prostatectomy

European urology open science (Online), 2020-07, Vol.19, p.e1398-e1399

2020

Volltextzugriff (PDF)

Impact of learning curve and technical changes on dosimetry in low-dose brachytherapy for prostate cancer

Strahlentherapie und Onkologie, 2012-12, Vol.188 (12), p.1091-1095

2012

Volltextzugriff (PDF)

Comparison between MRI and choline-PET trans-perineal target biopsies and saturation biopsies for detection and topography of intra-prostatic recurrence after primary radiation therapy for prostate cancer

Progrès en urologie (Paris), 2021-10, Vol.31 (12), p.683-691

2021

Volltextzugriff (PDF)

Cancers de prostate : quelles techniques de radiothérapie pour quelles tumeurs ? Enjeux éthiques et méthodologiques

Cancer radiothérapie, 2014-10, Vol.18 (5-6), p.369-378

2014

Volltextzugriff (PDF)

Soil Contamination due to E-Waste Disposal and Recycling Activities: A Review with Special Focus on China

Pedosphere, 2012-08, Vol.22 (4), p.434-455

2012

Volltextzugriff (PDF)

Radiothérapie postopératoire des cancers de la prostate

Cancer radiothérapie, 2014-10, Vol.18 (5-6), p.517-523

2014

Volltextzugriff (PDF)

70 Gy versus (vs) 80 Gy Dose Escalation Getug 06 French Trial for Localized Prostate Cancer: Mature Results

International journal of radiation oncology, biology, physics, 2008, Vol.72 (1), p.S96-S97

2008

Volltextzugriff (PDF)

Hypofractionnement à visée curative dans le cancer de la prostate

Cancer radiothérapie, 2013-10, Vol.17 (5-6), p.349-354

2013

Volltextzugriff (PDF)

Late Toxicity in the GETUG 06 Randomized Trial Comparing 70 Gy and 80 Gy for Localized Prostate Cancer

International journal of radiation oncology, biology, physics, 2007-11, Vol.69 (3), p.S319-S319

2007

Volltextzugriff (PDF)

Antibiotics versus no therapy in kidney transplant recipients with asymptomatic bacteriuria (BiRT): a pragmatic, multicentre, randomized, controlled trial

Clinical microbiology and infection, 2021-03, Vol.27 (3), p.398-405

2021

Volltextzugriff (PDF)

Biopsies des vésicules séminales : intérêt dans le bilan d’extension du cancer de la prostate avant radiothérapie ou curiethérapie

Progrès en urologie (Paris), 2011-09, Vol.21 (8), p.534-541

2011

Volltextzugriff (PDF)

OC-0433 GETUG-AFU 22 phase II randomized trial : final results on clinical outcomes with immediate SRT

Radiotherapy and oncology, 2023-05, Vol.182, p.S334-S334

2023

Volltextzugriff (PDF)

Generic Issues on Broad-Scale Soil Monitoring Schemes： A Review

Pedosphere, 2012-08, Vol.22 (4), p.456-469

2012

Volltextzugriff (PDF)

Multisite validation study of questionnaire assessing out-patient satisfaction with care questionnaire in ambulatory chemotherapy or radiotherapy treatment

Bulletin du cancer, 2006-03, Vol.93 (3), p.315

2006

Volltextzugriff (PDF)

Late Toxicity and Quality of Life from GETUG-AFU 22 Study: A Multicenter Randomized Phase II Trial Comparing Radiotherapy +/- 6 Months of Degarelix as a Salvage Treatment for Patients with Detectable PSA after Radical Prostatectomy

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.S134-S134

2019

Volltextzugriff (PDF)

Toxicité tardive et qualité de vie de l’étude GETUG-AFU 22

Progrès en urologie (Paris), 2019-11, Vol.29 (13), p.759-759

2019

Volltextzugriff (PDF)

Patterns of Daily Practice of Hormone Therapy in Unfavorable and Favorable Intermediate-Risk Prostate Cancer: Results of the French PROACT Survey

International journal of radiation oncology, biology, physics, 2017-10, Vol.99 (2), p.E213-E213

2017

Volltextzugriff (PDF)

5500 ORAL Induction chemotherapy for larynx preservation. Updated results of the GORTEC 2000–01 randomized trial comparing docetaxel + cisplatinum + fluorouracil (TPF) versus cisplatinum + fluorouracil (PF)

European journal of cancer supplements, 2007, Vol.5 (4), p.324-324

2007

Volltextzugriff (PDF)

Clinical and dosimetric analysis of 469 prostate cancer patients treated in France in 2005 by permanent implant brachytherapy using the Iodin 125 seeds IsoSeed Bebig: report to the French Economic committee of health products (CEPS)

Cancer radiothérapie, 2007-06, Vol.11 (4), p.206

2007

Volltextzugriff (PDF)

Prostate cancer: what treatment techniques for which tumors? Ethical and methodological issues

Cancer radiothérapie, 2014-10, Vol.18 (5-6), p.369

2014

Volltextzugriff (PDF)

The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: Feasibility and acute toxicity

International journal of radiation oncology, biology, physics, 2004-11, Vol.60 (4), p.1056-1065

2004

Volltextzugriff (PDF)

1 – 25 von 444

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(360)
Mit Volltextzugriff
(416)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(190)
Life Sciences & Biomedicine
(174)
Life Sciences
(150)
Humans
(113)
Male
(68)
Female
(67)
Biological And Medical Sciences
(56)
Adult
(44)
Agriculture
(42)
Reproductive Biology
(41)
Fundamental And Applied Biological Sciences. Psychology
(39)
Oncology
(33)
Middle Aged
(32)
Aged
(30)
Agricultural Sciences
(30)
Agronomy. Soil Science And Plant Productions
(30)
Obstetrics & Gynecology
(29)
Environmental Sciences
(28)
Pregnancy
(25)
Sciences Biologiques Et Medicales
(25)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Neoadjuvant Androgen Deprivation Therapy for Prostate Volume Reduction, Lower Urinary Tract Symptom Relief and Quality of Life Improvement in Men with Intermediate- to High-risk Prostate Cancer: A Randomised Non-inferiority Trial of Degarelix versus Goserelin plus Bicalutamide

Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology group

Concurrent Chemoradiation Therapy Versus Acceleration of Radiation Therapy With or Without Concurrent Chemotherapy in Locally Advanced Head and Neck Carcinoma (GORTEC 99-02): 7-Year Survival Data From a Phase 3 Randomized Trial and Prognostic Factors

Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial

Late toxicity and quality of life from GETUG-AFU 22 study: A randomized phase II trial comparing 6 months of degarelix in combination with radiotherapy to radiotherapy alone for patients with detectable PSA after radical prostatectomy

Impact of learning curve and technical changes on dosimetry in low-dose brachytherapy for prostate cancer

Comparison between MRI and choline-PET trans-perineal target biopsies and saturation biopsies for detection and topography of intra-prostatic recurrence after primary radiation therapy for prostate cancer

Cancers de prostate : quelles techniques de radiothérapie pour quelles tumeurs ? Enjeux éthiques et méthodologiques

Soil Contamination due to E-Waste Disposal and Recycling Activities: A Review with Special Focus on China

Radiothérapie postopératoire des cancers de la prostate

70 Gy versus (vs) 80 Gy Dose Escalation Getug 06 French Trial for Localized Prostate Cancer: Mature Results

Hypofractionnement à visée curative dans le cancer de la prostate

Late Toxicity in the GETUG 06 Randomized Trial Comparing 70 Gy and 80 Gy for Localized Prostate Cancer

Antibiotics versus no therapy in kidney transplant recipients with asymptomatic bacteriuria (BiRT): a pragmatic, multicentre, randomized, controlled trial

Biopsies des vésicules séminales : intérêt dans le bilan d’extension du cancer de la prostate avant radiothérapie ou curiethérapie

OC-0433 GETUG-AFU 22 phase II randomized trial : final results on clinical outcomes with immediate SRT

Generic Issues on Broad-Scale Soil Monitoring Schemes： A Review

Multisite validation study of questionnaire assessing out-patient satisfaction with care questionnaire in ambulatory chemotherapy or radiotherapy treatment

Late Toxicity and Quality of Life from GETUG-AFU 22 Study: A Multicenter Randomized Phase II Trial Comparing Radiotherapy +/- 6 Months of Degarelix as a Salvage Treatment for Patients with Detectable PSA after Radical Prostatectomy

Toxicité tardive et qualité de vie de l’étude GETUG-AFU 22

Patterns of Daily Practice of Hormone Therapy in Unfavorable and Favorable Intermediate-Risk Prostate Cancer: Results of the French PROACT Survey

5500 ORAL Induction chemotherapy for larynx preservation. Updated results of the GORTEC 2000–01 randomized trial comparing docetaxel + cisplatinum + fluorouracil (TPF) versus cisplatinum + fluorouracil (PF)

Clinical and dosimetric analysis of 469 prostate cancer patients treated in France in 2005 by permanent implant brachytherapy using the Iodin 125 seeds IsoSeed Bebig: report to the French Economic committee of health products (CEPS)

Prostate cancer: what treatment techniques for which tumors? Ethical and methodological issues

The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: Feasibility and acute toxicity

Suchergebnisse filtern